Search
for
Sort by
Research 511–540 of 1000+
- Evidence-based approach to cutaneous hyperandrogenism in women
- Cutaneous Side Effects of Oral Contraceptives
- Update on the dermatologic use of systemic glucocorticosteroids
- Drug-Induced Hair Disorders
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Androgens in women
- Sexuality in premature ovarian insufficiency
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Endocrine evaluation of hirsutism
- Women's midlife health Reframing menopause
- Gender-Affirming Hormone Therapy for Transgender Men
- Obesity and the Polycystic Ovary Syndrome
- The rationale for physiological testosterone replacement in women
- Hidradenitis Suppurativa
- Androgen antagonists in androgen target tissues
- How to Diagnose Hair Loss
- Hormonal therapies for acne
- The placebo effect and randomized trials: analysis of conventional medicine
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Adverse health effects of androgen use
- Stem cells and aberrant signaling of molecular systems in skin aging
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)